Back to the Open Platform
NCD Resource Library
SEARCH LIBRARY:
FILTER:
mobile menu
Interim recommendations for use of the Pfizer–BioNTech COVID-19 vaccine, BNT162b2, under Emergency Use Listing
Resources List
CHEMIN DES MINES 9 P.O. BOX 195 1211 GENEVA 20 SWITZERLAND
+41 22 338 32 00 INFO@ACCESSACCELERATED.ORG
TERMS OF SERVICE
PRIVACY POLICY
Powered by
The data on company programs is pulled from public information companies have made available on those programs. 62 programs in the open platform are based on the data those companies have submitted to the Access Observatory at Boston University. The data for these programs has been reviewed by both the companies and the Access Observatory team. The open platform also leverages the taxonomy of strategies and activities that Access Accelerated engaged Boston University to develop to characterize and aggregate the contribution of Access Accelerated efforts. The open platform includes an additional 27 company programs that have not yet gone through the more comprehensive Access Observatory process.
